Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
2 other identifiers
interventional
530
12 countries
60
Brief Summary
The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 schizophrenia
Started Aug 2001
Shorter than P25 for phase_4 schizophrenia
60 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2001
CompletedFirst Submitted
Initial submission to the registry
May 7, 2002
CompletedFirst Posted
Study publicly available on registry
May 8, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2002
CompletedJuly 19, 2006
July 1, 2006
May 7, 2002
July 18, 2006
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- You must be between the ages of 18 and 75. If you have reached your 76th birthday, you will not be able to participate
- You must have been diagnosed with schizophrenia
- You must be able to visit the doctor's office as scheduled for the next 7 months
You may not qualify if:
- You have a serious medical illness, such as heart, liver, or kidney disease (Note: If you are uncertain about a particular condition, discuss it with your doctor.)
- You are either pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (60)
Unknown Facility
El Centro, California, United States
Unknown Facility
Glendale, California, United States
Unknown Facility
Sherman Oaks, California, United States
Unknown Facility
Middleton, Connecticut, United States
Unknown Facility
Norwich, Connecticut, United States
Unknown Facility
Melbourne, Florida, United States
Unknown Facility
Miami, Florida, United States
Unknown Facility
Atlanta, Georgia, United States
Unknown Facility
Chicago, Illinois, United States
Unknown Facility
Hoffman Estates, Illinois, United States
Unknown Facility
Lafayette, Indiana, United States
Unknown Facility
Rockville, Maryland, United States
Unknown Facility
Newton, Massachusetts, United States
Unknown Facility
Saint Charles, Missouri, United States
Unknown Facility
New York, New York, United States
Unknown Facility
Olean, New York, United States
Unknown Facility
Staten Island, New York, United States
Unknown Facility
Cincinnati, Ohio, United States
Unknown Facility
Portland, Oregon, United States
Unknown Facility
Philadelphia, Pennsylvania, United States
Unknown Facility
Austin, Texas, United States
Unknown Facility
El Paso, Texas, United States
Unknown Facility
Houston, Texas, United States
Unknown Facility
Terrell, Texas, United States
Unknown Facility
Richmond, Virginia, United States
Unknown Facility
La Plata, Buenos Aires, Argentina
Unknown Facility
Godoy Cruz, Mendoza Province, Argentina
Unknown Facility
Buenos Aires, Argentina
Unknown Facility
Ciudad de Buenos Air, Argentina
Unknown Facility
Graz, Austria
Unknown Facility
Innsbruck, Austria
Unknown Facility
Linz, Austria
Unknown Facility
Wein, Austria
Unknown Facility
Wels, Austria
Unknown Facility
Salvador, Estado de Bahia, Brazil
Unknown Facility
Aparecida de Goiânia, Goiás, Brazil
Unknown Facility
Pelotas, Rio Grande do Sul, Brazil
Unknown Facility
Sau Paulo, Sau Paulo, Brazil
Unknown Facility
Rio de Janeiro, Brazil
Unknown Facility
Essen, Germany
Unknown Facility
Hamburg, Germany
Unknown Facility
Tübingen, Germany
Unknown Facility
Dublin, Ireland
Unknown Facility
Mexico City, Mexico
Unknown Facility
Lima, Peru
Unknown Facility
Cidra, Puerto Rico
Unknown Facility
Ponce, Puerto Rico
Unknown Facility
Rio Piedras, Puerto Rico
Unknown Facility
San Juan, Puerto Rico
Unknown Facility
Barcelona, Barcelona, Spain
Unknown Facility
San Boi de Llobregat, Barcelona, Spain
Unknown Facility
Elizondo, Navarre, Spain
Unknown Facility
Pamplona, Navarre, Spain
Unknown Facility
Langreo, Principality of Asturias, Spain
Unknown Facility
Camberwell, London, United Kingdom
Unknown Facility
London, London, United Kingdom
Unknown Facility
Kings Lynn, Norfolk, United Kingdom
Unknown Facility
Paisley, Scotland, United Kingdom
Unknown Facility
Guildford, Surrey, United Kingdom
Unknown Facility
Caracas, Venezuela
Related Publications (1)
Liu-Seifert H, Ascher-Svanum H, Osuntokun O, Jen KY, Gomez JC. Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics. BMC Psychiatry. 2011 May 17;11:87. doi: 10.1186/1471-244X-11-87.
PMID: 21586165DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
May 7, 2002
First Posted
May 8, 2002
Study Start
August 1, 2001
Study Completion
July 1, 2002
Last Updated
July 19, 2006
Record last verified: 2006-07